A Comparison of Outcomes for Cord Blood Transplantation and Unrelated Bone Marrow Transplantation in Adult Aplastic Anemia
- PMID: 27401034
- DOI: 10.1016/j.bbmt.2016.07.002
A Comparison of Outcomes for Cord Blood Transplantation and Unrelated Bone Marrow Transplantation in Adult Aplastic Anemia
Abstract
Earlier reports suggested that umbilical cord blood transplantation (UCBT) for aplastic anemia (AA) was feasible in alternative transplantation. To identify differences in outcomes of UCBT and HLA-matched or mismatched unrelated bone marrow transplantation (UBMT) in adults with AA, we analyzed registry data of the Japan Society for Hematopoietic Cell Transplantation and compared results of UCBT (n = 69) to 8/8-matched (n = 101), 7/8-matched (n = 65), or 6/8-matched (n = 37) UBMT. The transplantation period was from 2002 to 2012, and patients 16 years or older with AA were eligible. Median ages were 49, 35, 28, and 30 years for UCBT, 8/8-matched, 7/8-matched, and 6/8-matched UBMT, respectively. In multivariate analysis, risk of mortality was lower for 8/8-matched UBMT compared with that of UCBT (hazard ratio [HR], .55; 95% confidence interval [CI], .32 to .94; P = .029), adjusted for age and graft-versus-host disease (GVHD) prophylaxis, which were other associated factors. Mortality risks of 7/8-matched UBMT (HR, .55; 95% CI, .29 to 1.02) or 6/8-matched UBMT (HR, .67; 95% CI, .32 to 1.39) were not significantly different from those of UCBT. Risks of grade 3 or 4 acute and chronic GVHD were not different among the 4 groups. The most prevalent cause of death was graft failure in UCBT and 6/8-matched UBMT and infection in 8/8-matched and 7/8-matched UBMT. Under 40 years old,survival of UCBT was similar to that of UBMT (76%, 79%, 83%, and 83% for UCBT and 8/8-matched, 7/8-matched, and 6/8-matched UBMT, respectively, at 3 years), adjusted for transplantation period, which was another associated factor; however, for ages over 40 years, that of UCBT tended to be lower (47%, 64%, 64%, and 75% for UCBT, 8/8-matched, 7/8-matched, and 6/8-matched UBMT, respectively, at 3 years). To conclude, these data suggest that UCBT could be an alternative treatment option for younger adults when matched sibling or adequate UBMT donors are not available.
Keywords: Aplastic anemia; Cord blood transplantation; Unrelated bone marrow transplantation.
Copyright © 2016 The American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Updated Comparison of 7/8 HLA Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Umbilical Cord Blood Transplantation as Alternative Donors in Adults with Acute Leukemia.Biol Blood Marrow Transplant. 2020 Nov;26(11):2105-2114. doi: 10.1016/j.bbmt.2020.08.001. Epub 2020 Aug 9. Biol Blood Marrow Transplant. 2020. PMID: 32784070
-
Comparative outcomes between cord blood transplantation and bone marrow or peripheral blood stem cell transplantation from unrelated donors in patients with hematologic malignancies: a single-institute analysis.Chin Med J (Engl). 2013 Jul;126(13):2499-503. Chin Med J (Engl). 2013. PMID: 23823825
-
Comparison of Outcomes of 8/8 and 7/8 Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia.Biol Blood Marrow Transplant. 2016 Feb;22(2):330-338. doi: 10.1016/j.bbmt.2015.10.006. Epub 2015 Oct 22. Biol Blood Marrow Transplant. 2016. PMID: 26476205
-
A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in acute leukemia patients.Biol Blood Marrow Transplant. 2012 Aug;18(8):1164-73. doi: 10.1016/j.bbmt.2012.01.015. Epub 2012 Jan 28. Biol Blood Marrow Transplant. 2012. PMID: 22289799 Review.
-
A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients.Biol Blood Marrow Transplant. 2007 Apr;13(4):444-53. doi: 10.1016/j.bbmt.2006.11.005. Epub 2007 Feb 15. Biol Blood Marrow Transplant. 2007. PMID: 17382250
Cited by
-
Long-Term Outcome of Eltrombopag With First-Line Immunosuppressive Therapy for Newly Diagnosed Severe Aplastic Anemia.J Hematol. 2024 Aug;13(4):142-149. doi: 10.14740/jh1289. Epub 2024 Aug 10. J Hematol. 2024. PMID: 39247063 Free PMC article.
-
Changes in the incidence, patterns and outcomes of graft failure following hematopoietic stem cell transplantation for Hurler syndrome.Bone Marrow Transplant. 2017 Jun;52(6):846-853. doi: 10.1038/bmt.2017.5. Epub 2017 Feb 20. Bone Marrow Transplant. 2017. PMID: 28218755 Clinical Trial.
-
Public Awareness on Cord Blood Banking in Saudi Arabia.Stem Cells Int. 2018 Apr 3;2018:8037965. doi: 10.1155/2018/8037965. eCollection 2018. Stem Cells Int. 2018. PMID: 29765424 Free PMC article.
-
Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy.Haematologica. 2023 Dec 1;108(12):3298-3307. doi: 10.3324/haematol.2023.282781. Haematologica. 2023. PMID: 37259612 Free PMC article.
-
[Single non-blood-related umbilical cord blood transplantation using a reduced-intensity conditioning regimen for the treatment of severe aplastic anemia].Zhonghua Xue Ye Xue Za Zhi. 2024 Jan 14;45(1):68-73. doi: 10.3760/cma.j.issn.0253-2727.121090-20230928-00146. Zhonghua Xue Ye Xue Za Zhi. 2024. PMID: 38527841 Free PMC article. Chinese.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials